全文获取类型
收费全文 | 1372篇 |
免费 | 67篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 52篇 |
妇产科学 | 50篇 |
基础医学 | 157篇 |
口腔科学 | 10篇 |
临床医学 | 144篇 |
内科学 | 239篇 |
皮肤病学 | 17篇 |
神经病学 | 129篇 |
特种医学 | 26篇 |
外科学 | 178篇 |
综合类 | 10篇 |
一般理论 | 1篇 |
预防医学 | 191篇 |
眼科学 | 7篇 |
药学 | 156篇 |
肿瘤学 | 65篇 |
出版年
2023年 | 6篇 |
2022年 | 8篇 |
2021年 | 16篇 |
2020年 | 10篇 |
2019年 | 20篇 |
2018年 | 19篇 |
2017年 | 20篇 |
2016年 | 20篇 |
2015年 | 35篇 |
2014年 | 32篇 |
2013年 | 82篇 |
2012年 | 70篇 |
2011年 | 75篇 |
2010年 | 39篇 |
2009年 | 55篇 |
2008年 | 97篇 |
2007年 | 101篇 |
2006年 | 66篇 |
2005年 | 98篇 |
2004年 | 81篇 |
2003年 | 75篇 |
2002年 | 80篇 |
2001年 | 11篇 |
2000年 | 12篇 |
1999年 | 7篇 |
1998年 | 23篇 |
1997年 | 19篇 |
1996年 | 16篇 |
1995年 | 23篇 |
1994年 | 10篇 |
1993年 | 17篇 |
1992年 | 20篇 |
1991年 | 15篇 |
1990年 | 7篇 |
1989年 | 11篇 |
1988年 | 15篇 |
1987年 | 15篇 |
1986年 | 13篇 |
1985年 | 15篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 9篇 |
1981年 | 7篇 |
1980年 | 5篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1976年 | 5篇 |
1972年 | 5篇 |
1971年 | 3篇 |
排序方式: 共有1442条查询结果,搜索用时 0 毫秒
1.
S Bj?rck M Aurell L E Bres?ter H Herlitz L Welin J Wikstrand 《Scandinavian journal of urology and nephrology》1990,24(4):267-273
The role of the renin angiotensin system for the regulation of kidney function in diabetes mellitus is uncertain. Results from studies in diabetic animals suggest that a reduced activity in this system contributes to the renal hyperperfusion and hyperfiltration in diabetes. The renal sensitivity to angiotensin II in diabetic patients is also unknown. Changes in renal hemodynamics were measured after infusion of two low doses of angiotensin II in ten young type 1 diabetic patients without complications and in ten healthy controls. The renin and angiotensin II levels were found to be the same in both groups. The baseline glomerular filtration rate was higher in the diabetics. During the highest angiotensin II dose, the 51Cr-EDTA and PAH clearance decreased 14 +/- 15 and 157 +/- 118 ml/min in the diabetics and 14 +/- 15 and 146 +/- 109 in the controls respectively. The changes in blood pressure and renal vascular resistance or sodium excretion did not differ between the groups. A malfunction of the renin angiotensin system is thus unlikely as a cause of the glomerular hyperfiltration in type 1 diabetes. 相似文献
2.
3.
Staffan Eksborg Lennart Hardell Nils-Olof Bengtsson Marie Sjödin Birgitta Elfsson 《Medical oncology (Northwood, London, England)》1992,9(2):75-80
Sixty women with breast cancer (mean age: 61 years; range 36-78 years) were treated with Epirubicin (4’epi-Dox-orubicin),
60 mg m-2 , as single drug therapy. The drug was administered as 2 hours’ constant rate infusions. The pharmacokinetics of the drug
during the first course of treatment was evaluated by measurements of the plasma concentration of Epirubicin at the end of
the infusion period.
There was a five-fold inter-individual variation of the dose-normalized maximum plasma concentration, which increased with
increasing age of the patients. There was no correlation between this pharmacokinetic parameter and degree of obesity. 相似文献
4.
Tsuchida H Björnholm M Fernström M Galuska D Johansson P Wallberg-Henriksson H Zierath JR Lake S Krook A 《Pflügers Archiv : European journal of physiology》2002,445(1):25-31
The gene of the p85alpha regulatory subunit of phosphatidylinositol (PI) 3-kinase gives rise to several splice variants. We hypothesized that the expression of p85alpha splice variants may be altered in skeletal muscle from subjects with type 2 diabetes mellitus. Skeletal muscle biopsies were obtained from nine type 2 diabetic and eight healthy men, matched for age, body mass index (BMI) and physical fitness. PI 3-kinase activity in skeletal muscle following in vitro insulin stimulation was reduced in subjects with type 2 diabetes. p85alpha mRNA was elevated fourfold in type 2 diabetic as compared to healthy control subjects ( P<0.05). p85alpha mRNA abundance was positively correlated with plasma insulin concentration ( P<0.01) and serum glucose concentration ( P<0.01). Despite this, protein levels of p85alpha, p55alpha, and the novel human p50alpha were not altered in type 2 diabetic subjects. Thus, although gene expression of full-length p85alpha is increased in skeletal muscle from type 2 diabetics, this is not reflected by increased protein levels. Therefore, defects in PI 3-kinase activity are likely due to impaired activation of the enzyme rather than changes in protein expression of the isoforms of the regulatory subunit. 相似文献
5.
6.
Pia Bjrck Carina Elenstrm-Magnusson Anders Rosn Eva Severinson Staffan Paulie 《European journal of immunology》1993,23(8):1771-1775
We have previously found that interleukin-4 and CD40 monoclonal antibodies (mAb) are strong potentiatiors of homotypic B cell aggregation which is dependent on LFA-1. We show here that CD23 mAb were also able to inhibit aggregation to a similar extent as LFA-1 antibodies. This inhibition was restricted to the MHM6 epitope of CD23 and antibodies to other epitopes [Epstein-Barr virus (EBV) CS-1, EBV CS-2, EBV CS-5 and mAb 25] or occupation of the Fc-binding site by IgE had no or a slightly enhancing effect on aggregation. When testing two antibodies to CD21, the recently defined ligand for CD23, one of these (BU32) was found to be inhibitory whereas the other (THB5) had no effect. By combining antibodies to LFA-1 and CD23, aggregation was often completely inhibited. These data suggest that LFA-1/ICAM-1 and CD23/CD21 are the major molecules involved in homotypic aggregation of human B cells. 相似文献
7.
Zuber B Levitsky V Jönsson G Paulie S Samarina A Grundström S Metkar S Norell H Callender GG Froelich C Ahlborg N 《Journal of immunological methods》2005,302(1-2):13-25
The perforin (PFN) protein is essential for the elimination of target cells by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. The study of cells releasing PFN has been hampered by a lack of sensitive methods. We therefore produced PFN-reactive monoclonal antibodies (mAb) and developed capture enzyme-linked immunosorbent (ELISA) and enzyme-linked immunospot (ELISpot) assays. Three mAbs were generated and shown to react with unique determinants of PFN. All mAbs recognized intracellular PFN in human peripheral blood mononuclear cell (PBMC) as assessed by flow cytometry and immunohistochemistry. Functional PFN capture ELISA and ELISpot assays were developed utilizing two of the mAbs for capture and the third mAb for detection. When examining PFN release by the YT lymphoma cell line, the ELISpot displayed a greater detection sensitivity than the ELISA. Assessment of PFN release by a CTL clone using ELISpot gave results consistent with a parallel (51)Cr-release cytotoxicity assay. Moreover, PFN release by PBMC could be quantified by ELISpot and ELISA after ex vivo stimulation with defined CTL epitopes from common viruses. These novel immunoassays will be valuable for further investigations of the mechanisms underlying granule-mediated apoptosis. In addition, the capture immunoassays could provide tools for studying CTL responses in infectious and tumor diseases as well as for vaccine development. 相似文献
8.
Brodin L Theordorsson E Christenson J Cullheim S Hökfelt T Brown JC Buchan A Panula P Verhofstad AA Goldstein M 《The European journal of neuroscience》1990,2(12):1095-1109
Neurotensin (NT)-like peptides in the CNS of the lamprey Lampetra fluviatilis were studied by radioimmunoassay (C-terminal specific NT antiserum), reverse-phase HPLC and immunohistochemistry. Multiple peaks of NT-immunoreactive (-ir) material were observed upon HPLC, of which a major peak eluted in the position of bovine NT. Immunofluorescence histochemistry showed that a monoclonal antibody recognizing the N-terminal (1 - 11) fragment of NT, as well as two polyclonal NT antisera labelled a large number of cell bodies in the periventricular area of hypothalamus, including the postinfundibular commissural nucleus and the ventral and dorsal hypothalamic nuclei. Additional groups of NT-ir cells were observed in the preoptic nucleus, the postoptic commissural nucleus, the mesencephalic tegmentum (L.fluviatilis), and in the spinal cord (L.fluviatilis and Ichtyomyzon unicuspis). Dense NT-ir fibre plexuses were present in the caudal hypothalamus, corpus striatum, ventral mesencephalon, and in the dorsal horn and lateral margin of the spinal cord. At the ultrastructural level the lateral spinal margin showed NT-ir terminal structures, which in most cases were not associated with synaptic specializations, although occasional synaptic contacts with unlabelled elements were found. The relation between NT-ir and monoamine-containing cells was examined with immunofluorescence double-staining, using antisera to tyrosine hydroxylase (TH), 5-hydroxytryptamine (5-HT), and histamine respectively. In the periventricular nuclei of hypothalamus numerous TH-, 5-HT-, as well as histamine-ir cells were located in close association with NT-ir cells, but none of the aminergic markers could be detected within NT-ir neurons. The chemical properties as well as the anatomical distribution of lamprey NT-like peptides show several similarities with those present in mammals, suggesting that NT-containing neuronal systems in the CNS developed early in vertebrate phylogeny. 相似文献
9.
10.
Viera Reichelová Gunnar Juliusson Tatiana Spasokoukotskaja Staffan Eriksson Jan Liliemark 《Cancer chemotherapy and pharmacology》1995,36(6):524-529
2-Chloro-2-deoxyadenosine (CdA, Cladribine), is a purine antimetabolite currently under investigation in phase II clinical trials for the treatment of lymphoid malignancies. Significant differences in CdA toxicity between mice and humans were observed during phase I clinical evaluation. For the elucidation of interspecies differences in drug toxicity the pharmacokinetics of CdA after subcutaneous injection and the kinetic properties of the CdA-phosphorylating enzyme, deoxycytidine kinase (dCK), were compared in mice and humans. The ratio of the dose lethal to 10% of mice (LD10) to the maximum tolerated dose (MTD) in humans was 50 and the ratio of the area under the curve obtained at approximately one-half the LD10 (AUCapprox. one-half the LD
10)/AUCMTD was 49. A significant interspecies difference was observed in the kinetic properties of dCK, the main CdA-activating enzyme. With CdA as a substrate, the Michaelis constant (K
m) of dCK in crude extracts of mouse thymus was 10 times higher than that in human thymus. An approximately 9-fold interspecies difference in maximum velocity (Vmax)/K
m indicated a higher efficiency of dCK for CdA in humans than in mice. The peak plasma concentration was 210 times higher and exceeded theK
m in mice. Initial and terminal half-lives were approximately 7 times shorter in mice and trough levels were similar in mice and humans. Thus, the differences in AUCs at equitoxic doses are largely explained by differences in the target enzyme properties and the pharmacokinetic pattern. The observed lower tolerance for CdA in humans as compared with mice confirms the view that antimetabolites may not be good candidates for pharmacokinetically guided dose-escalation schemes unless detailed information on interspecies variability in drug bioactivation is available. 相似文献